| ★ | What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata | | 82 | Estados Unidos | |
| 19 | Hair fall needs more than DIYs—blood tests help find the real cause. | Dr. Priyanka Reddy @drpriyankareddydermatologist | 262.3K | India | 85 |
| 12 | STOP Using Niacinamide Wrong! 😳 3 Mistakes You MUST Avoid | Dr. Sanchika Gupta.MD | Dr. Sanchika Gupta @dr.sanchikagupta | 941 | India | 85 |
| 2 | Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata | | 611 | Estados Unidos | 92 |
| 4 | Is Long-Term JAK Inhibitor Use Safe for #Alopecia Areata? | | 456 | Estados Unidos | 89 |
| 17 | 4 Game-Changing Products for Those Stubborn Dark Spots! Dr. Sanchika Gupta.MD | Dr. Sanchika Gupta @dr.sanchikagupta | 389 | India | 85 |
| 5 | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | 87 |
| 3 | How Much Hair Regrowth Did Upadacitinib Achieve in Severe Alopecia Areata? | | 196 | Estados Unidos | 91 |
| 9 | Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD | | 172 | Estados Unidos | 86 |
| 7 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 86 |
| 20 | How Are New Biologics Changing Atopic Dermatitis Treatment? | | 137 | Estados Unidos | 85 |
| 6 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 87 |
| 10 | Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD | | 102 | Estados Unidos | 86 |
| 1 | How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD | | 93 | Estados Unidos | 96 |
| 13 | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | 85 |
| 15 | Age-Stratified Phase 3 Data Support Tapinarof Cream in Pediatric Eczema | | 58 | Estados Unidos | 85 |
| 8 | Spotting Scarring Alopecia Before It's Too Late | | 42 | Estados Unidos | 86 |
| 11 | Can This Patch Really Bring Back Hair? | | 20 | — | 86 |
| 14 | BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS | | 14 | Estados Unidos | 85 |
| 16 | Delgocitinib & Hand Eczema: How Topical JAK Inhibitors Change the Treatment Sequence | Maui Derm | | 11 | Estados Unidos | 85 |
| 18 | Evolving Safety Considerations in Atopic Dermatitis Management | | 3 | Estados Unidos | 85 |